Student Feedback 2015

Dr. Tsuyoshi Shiga

• I had heard Dr. Shiga's lecture elsewhere before and found it very easy to understand. He speaks with pharmacists in mind, and his slides are designed for easy explanation rather than just quoting something, which helps when reviewing later. As expected, the content this time was also excellent. I would like to request him again. (40s, Hospital Pharmacist)

• Why do we need to treat atrial fibrillation? The CHADS2 score made it very clear. I also learned the difference between Warfarin and NOACs, and I intend to review them properly. (30s, Pharmacy Pharmacist)

• I was able to learn about drug selection methods and case studies from a physician's perspective, which deepened my knowledge of pathology and drugs. There were many things I can apply to medication guidance for patients. (Pharmacy Pharmacist)

• It was great to hear about actual field experiences with very clear explanations and data. The comparison of each drug was clear, and I think I can use it in my future work. (50s, Pharmacy Pharmacist)

Dr. Toshimi Kimura

• I understood creatinine clearance. I want to use it as a reference when reading package inserts. (40s, Pharmacist)

• I was able to learn from the basics, and combined with the first half of the lecture, my understanding deepened. The talk was based on various trial data and was helpful with evidence. There was also data showing that pharmacist intervention in drug therapy can improve patient adherence, which I want to use in future guidance. (Pharmacy Pharmacist)

• It made me think about the role of the pharmacist again. I felt that I need to try harder to improve adherence once more. (50s, Pharmacy Pharmacist)

• He gave a very clear lecture on a field that was very gray to me. Everything became very clear, and I feel like I can use it immediately in the field starting tomorrow. (50s, Pharmacy Pharmacist)

Dr. Akira Shimada

• Information on new drugs, etc., was helpful. I think there are many patients taking oral diabetes medications, and I would like to hear again about guidance when changing prescriptions for those drugs (that have been taken for a long time). (50s, Pharmacist)

• I had felt the recent prescription trends for diabetes drugs in my daily dispensing work, and I think it was good to learn the evidence in this lecture. (50s, Pharmacy Pharmacist)

• He gave detailed explanations for each drug, which was easy to understand. (30s, Pharmacy Pharmacist)

• The comparison of BG vs DPP4i was very interesting. It was also meaningful to have the merits and demerits of SGLT2 inhibitors explained in detail. (60s, Hospital Pharmacist)

• Recently, new hypoglycemic drugs have been coming onto the market one after another, and I didn't really understand on what basis prescriptions were decided, but I was able to understand how to choose based on the latest evidence. I think I can provide guidance with persuasiveness when actually giving medication guidance to patients. (30s, Pharmacy Pharmacist)

Dr. Tatsuya Muto

• Regarding insulin injections, I had experience with manufacturer training sessions (briefings), but there were many things I didn't know, such as auxiliary devices, which was helpful. (50s, Pharmacist)

• It was good to learn detailed instruction methods and points to note regarding insulin techniques. I want to apply this to patient guidance in the future. (50s, Pharmacy Pharmacist)

• There were stories that can be used in daily insulin instruction, and it was very easy to understand and interesting. (30s, Pharmacy Pharmacist)

• I had been handing out Levemir while feeling concerned, but after being taught specific techniques and storage temperatures, I think I can hand it out with peace of mind. The methods for taking it home were also very helpful. (60s, Hospital Pharmacist)

• I receive many insulin prescriptions at the dispensing pharmacy, but most people have received education at the hospital, and at the pharmacy, I only checked whether there was hypoglycemia. I hardly knew there were so many points to note in the process of the technique. Many patients say they have no problems, but I felt it was important to have the perspective of whether that is really the case. (30s, Pharmacy Pharmacist)

Dr. Takashi Eto

• There were many specific stories, and I felt they would be immediately useful in my work. Since most psoriasis patients are well-versed in their own illness and have been using medications for a long time, medication dispensing tends to become routine, so I will utilize today's talk. (40s, Pharmacy Pharmacist)

• The stories were all very interesting and exceeded my expectations. (50s, Office Worker)

• It was good to learn that new treatments are progressing for atopic dermatitis and psoriasis. I find it regrettable that treatment for patients does not progress because many medical professionals also have misunderstandings about steroids. (40s, Pharmacy Pharmacist)

Dr. Michitaka Otani

• I felt it would be important in the future to devise ways to efficiently absorb drugs or improve compliance based on the basics of bases learned at university. (20s, Drugstore Pharmacist)

• From the basics of topical skin medications to the characteristics of each generic drug, everything was explained in detail and in an easy-to-understand manner, and I was able to newly recognize the importance of topical agents. (Pharmacy Pharmacist)

• I understood knowledge often needed in daily work, such as ointment bases, how to apply, and frequency of application. (40s, Pharmacy Pharmacist)

• I think he provided good guidelines for things I had been wondering about in daily practice with practical stories. (60s, Hospital Pharmacist)

• I could really feel the enthusiasm of the professors in this lecture. I clearly understood that along with raising awareness and providing educational outreach for those who play sports, it is also necessary for the people around them, including us pharmacists, to provide assistance and improve our knowledge. I want to be able to prevent inadvertent doping, enjoy sports with everyone, and continue to protect its value (dignity). (40s, Pharmacy Pharmacist)

• I was able to listen to multifaceted stories from people active on the front lines, including inspectors, pharmacists, athletes, and doctors, all at once, which gave me a lot to think about in aiming to become a sports pharmacist. The existence of designer drugs, the fear of side effects from drugs, inadvertent doping, doping that is close at hand, ingredients listed on overseas supplements, characteristic physical reactions to the effects of doping, and measures against concealment. I want to continue learning so that I can contribute to the role of supporting the success of athletes who will carry the future.

• The impact of sports on society is larger than I imagined, and I felt that for us pharmacists to protect athletes from doping leads to protecting not only those athletes but also the future of children who aspire to do their best in sports and the dignity of the country. (20s, Hospital Pharmacist)

• The stories from the professors active in the field were very interesting and I enjoyed listening to them. I know Ben Johnson, Joyner, Bubka... I've loved sports since then!! I strongly felt that I want to move forward and promote what I can do as a sports pharmacist. (50s, Housewife)

• It was a good opportunity to learn the history of doping. I felt that I must properly convey that doping is not just a one-time problem, but also carries the risk of causing sudden cardiac death in the future and affecting one's own children. (20s, Hospital Pharmacist)

• The 2020 Olympics has the meaning of a "soft legacy"! I see!! I strongly felt that I want to look more at the "now" according to the times, which is a big difference from 1964, and engage in some activities as a sports pharmacist. (50s)

• I heard this for the first time. It was very helpful for the Olympics. I didn't know much about doping drugs in detail, but I could feel that even just learning a little bit is a big plus.

• It was very educational because I understood the general classification of infectious diseases encountered in the community. It was good because he explained it clearly, incorporating specific cases. I understood well the reason why Cravit became 500mg once daily (1x). (50s, Pharmacy Pharmacist)

• It was very educational to hear how doctors actually diagnose and select preparations in clinical settings. Regarding the concept of PK/PD, I recognized the necessity once again. (30s, Hospital Pharmacist)

• I learned a lot by being taught actual diagnosis and prescription decisions for each disease. In particular, my awareness of the diseases was insufficient, so it was very educational. (40s, Pharmacist)

• Dr. Kunishima's lecture was specific and very easy to understand. I often see prescriptions for antibiotics, but I often don't know the name of the disease. I felt that I must properly check the guidelines for healthcare-associated pneumonia. (40s, Pharmacy Pharmacist)

• It was very good to be able to study infectious diseases that cannot be read from daily work. I couldn't understand high-risk infectious diseases or pathologies just from prescriptions and talking with patients, but I felt this would be useful for understanding them even a little. I don't have the opportunity to consider antibiotic dosage design in my work, but I want to use this for understanding prescriptions and appropriate response to patients. It was an interesting and fascinating talk. (50s, Pharmacist)

• The lecture was interesting, incorporating current treatment guidelines and reference values. I want to carefully re-read the package inserts, accumulate knowledge, and work with responsibility in my daily duties. (Pharmacy Pharmacist)

• I was able to deepen my understanding as the lecturer repeatedly showed how to read GFR and serum Cr data in various cases. The explanations of CKD and AKI were easy to understand, and I learned with interest about their connection to cardiovascular events and the need for caution regarding their relationship with drugs most commonly used by the general public, such as NSAIDs. (50s, Pharmacist)

• In my daily work, I had the impression that many dialysis patients have cardiovascular disease and are more worried about that than the dialysis itself. Today's talk helped me understand that a high GFR is associated with a high risk of cardiovascular disease. (30s, Pharmacy Pharmacist)

• The lecture on the renal field, which I find difficult, was easy to understand and deepened my comprehension. I now clearly understand the definition of AKI and creatinine. The detailed explanation of points to look for in patients with reduced renal function was also very helpful. (30s, Hospital Pharmacist)

• The points to watch for in patients with reduced renal function and for renal-excretion type drugs were explained clearly. I plan to start a review and classification of medications at the pharmacy where I work. (40s, Pharmacy Pharmacist)

• Thank you for the very easy-to-understand lecture. I handle prescriptions for people with bipolar disorder, and I now clearly understand the key side effects to watch for. I also realized the importance of asking patients about their status in the future, as blood tests are rarely performed in psychiatry. (40s, Pharmacy Pharmacist)

• Through the presentation of extensive data, I was able to understand the pathology and treatment of bipolar disorder. Since valproic acid is frequently prescribed at our hospital as a preventive drug for migraines, I want to be mindful of side effects and interactions in the future. (Hospital Pharmacist)

• I only studied depression in university, but learning that bipolar disorder is also common made me realize the importance of continuous study. I felt it was a social loss that bipolar disorder is common among highly educated individuals. I would like to hear Professor Watanabe's lectures again. (30s)

• I was able to learn about the pathology unique to mental illness and the difficulty of diagnosis. As a pharmacist, I want to keep a close eye on the monitoring and drug interactions of antipsychotics. (20s, Hospital Pharmacist)

• In a small pharmacy, it is often difficult to ask patients about their condition or diagnosis, and there are almost no cases where I can infer the necessity from the medication, but today's talk was easy to understand and will be very helpful for that. (40s, Pharmacy Pharmacist)

• I once again felt the benefits of combination drugs and OD tablets. Improving adherence is the path to reducing medical costs—the professor is passionate and brilliant. (40s)

• Thank you for the easy-to-understand talk. I was surprised to see so many tablets stuck in the throat like that. I understood the importance and necessity of OD tablets. The ingenuity of pharmaceutical technology is also wonderful. Thank you for a very interesting lecture. (Pharmacy Pharmacist)

• Thank you for today. The image of tablets getting stuck in the throat left a strong impression, and I felt I must change my awareness. I was convinced by the video that even changing just one tablet to an OD tablet can reduce aspiration pneumonia. The printing on Pletal OD tablets is always helpful. I hope all other tablets will be printed as well. (40s, Pharmacy Pharmacist)

• I reaffirmed that improving adherence not only impacts therapeutic effects but also influences the resolution of leftover medication issues and the reduction of medical costs. I also well understood that easy-to-take medications are desired for this purpose. (50s, Pharmaceutical Company Employee)

• I found it very interesting that there are various factors such as pharmaceutical aspects, adherence, cost-effectiveness, drug prices, and opinions from medical associations before a drug enters the market. (50s, Pharmacy Pharmacist)

• The lecture was very easy to understand and thorough, allowing me to deepen my comprehension. I would like to utilize the fact that exercise therapy is effective, especially for chronic back pain, in my daily medication counseling. (40s, Pharmacy Pharmacist)

• I haven't been able to attend many public lectures on orthopedic surgery, but this time it was very easy to understand, starting from the basics and including plenty of images.

• It was very easy to understand. It was beneficial to learn that things I had considered common sense until now are actually not the case. (50s, Pharmacy Pharmacist)

• I haven't had many opportunities to hear lectures in the field of orthopedic surgery, so it was very helpful. (40s, Pharmacy Pharmacist)

• The symptoms for each disease and the points for judgment were very easy to understand and left an impression. I definitely want to use this when I receive questions from patients. (40s, Part-time Pharmacist)

• I thought it was important to judge breast cancer by taking biology into account. I want to distinguish between initial treatment and PPP and apply this to medication counseling. (50s, Pharmacy Pharmacist)

• Breast cancer, the theme of this session, has become a familiar disease, with relatives and friends being patients. As a pharmacist, I am often asked for advice, but until now, I didn't have much knowledge or awareness of the disease, so I couldn't give effective advice. By attending today's lecture, I was able to learn everything from the occurrence to current treatments, and I believe I can apply this in the future. (30s, Pharmacy Pharmacist)

• It was good to be taught from the basic treatment of breast cancer. My perspective on breast cancer screening has also changed. I was impressed by the commitment to never give up on treatment until the end and to always be by the patient's side. I was able to understand the causes of breast cancer and bone abnormalities. (60s, Pharmacy Pharmacist)

• I was able to hear many meaningful stories about the importance of understanding the nature of each cancer and treating it accordingly, rather than just early detection, as well as the latest breast cancer treatments. (20s, Hospital Pharmacist)

• When counseling patients, I sometimes didn't understand the doctor's intentions and was at a loss for what to say, so it was good to understand that today. (40s, Hospital Pharmacist)

• I learned that in cancer treatment, it is first important to identify the nature of that cancer. I understood how the prognosis of a patient is affected by which hospital and which doctor they see. It was a very informative lecture. (30s, Pharmaceutical Company Employee)

• As a pharmacist, I reaffirmed the need to deepen my understanding of food and health and to contribute as a participant in the new system for Foods with Function Claims. The story of the professor's own experience in changing his eating habits was also very helpful. (50s, Pharmaceutical Company)

• From the perspective of someone working in a drugstore, it was a very good talk that is actually useful on the front lines. (30s, Drugstore Employee)

• Since there are many inquiries about whether it is okay to take health foods with medicines or for one's own illness, a lecture like this is helpful as knowledge. (50s, Hospital Pharmacist)

• The content was very interesting and entertaining. To be honest, I had thought lightly of food compared to medicines, so I was surprised by many things I heard. (40s, Housewife)

• There were familiar topics, and I listened with interest. I felt I must be careful about exaggerated advertising for health foods. I think it was a very good lecture. (50s, Part-time Pharmacist)

• The talk from an expert knowledgeable in both food and medicine is precious, so it was very informative. (20s, Civil Servant)

• It was good to be able to learn various things about the harms of food. There were many useful things regarding the way food should be, and how to respond to and care for oneself, family, and patients, and I gained much learning. (30s, Pharmacy Pharmacist)

• I was able to reconfirm health foods, which I thought I understood somewhat until now. Even if I wanted to know, I didn't know where to start and it was a field I had left alone. The professor's talk was easy to understand, and time flew by listening to "interesting stories (behind-the-scenes)". (Age/Occupation not provided)

• Health comes from food! I well understood this basic but most important point. A few years ago, I thought about getting the NR qualification but eventually gave up, but I thought I would try hard again, including the Health Food Manager. (30s, Pharmacy Pharmacist)